Protalix BioTherapeutics, Inc. Other Receivables, Net, Current
Protalix BioTherapeutics, Inc. (PLX) had Other Receivables, Net, Current of $2.07 million as of 2014-09-30, per its 10-Q filed 2014-11-10.
Discontinued › Notes
us-gaap:OtherReceivablesNetCurrent · last filed 2014-11-10
- 2014-09-30: Other Receivables, Net, Current $2.07M.
- 2014-06-30: Other Receivables, Net, Current $1.99M.
- 2014-03-31: Other Receivables, Net, Current $2.61M.
- 2013-12-31: Other Receivables, Net, Current $1.46M.
| Period end | Other Receivables, Net, Current |
|---|---|
| 2014-09-30 | $2.07M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $1.99M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $2.61M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $1.46M 10-Q · filed 2014-11-10 |
| 2013-09-30 | $4.17M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $3.58M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $3.55M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $3.69M 10-K · filed 2014-03-13 |
| 2012-09-30 | $3.28M 10-Q · filed 2012-11-07 |
| 2012-06-30 | $4.04M 10-Q · filed 2012-08-03 |
| 2012-03-31 | $3.15M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $3.84M 10-K · filed 2013-02-28 |
| 2011-09-30 | $3.02M 10-Q · filed 2011-11-07 |
| 2011-06-30 | $4.88M 10-Q · filed 2011-08-08 |
| 2010-12-31 | $2.23M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |